NAV declined 5% to SEK 37.4 billion, mainly due to a full write-down of VillageMD, while core companies grew in value and are expected to reach profitability in 2025. Major investments were made in Spring Health and Aira, and the portfolio is now more concentrated in high-performing assets.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.